Dijkmans B A, Mattie H
Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.
Eur J Clin Pharmacol. 1987;33(2):179-83. doi: 10.1007/BF00544564.
The study was undertaken to look for a correlation between the measured elimination rate constants (k) of aminoglycosides and creatinine during haemodialysis. The pharmacokinetics of aminoglycosides were studied during 44 courses of haemodialysis in 21 patients. The measured k of gentamicin and tobramycin from the start until 30 min after the end of haemodialysis (mean 0.18 h-1; t1/2 = 3 h 51 min) was significantly correlated with the measured k of creatinine (mean 0.13 h-1; t1/2 = 5 h, 20 min), and also with the gentamicin and tobramycin k during haemodialysis (mean 0.20 h-1, t1/2 = 3 h, 28 min), as predicted by a computer program. Thus, serum concentrations of aminoglycosides 30 min after haemodialysis can be estimated by simple regression equations. However, because the measured and predicted values may diverge considerably in the individual patient, monitoring of aminoglycoside concentrations in serum after haemodialysis remains necessary.
本研究旨在探寻血液透析期间氨基糖苷类药物与肌酐的实测消除速率常数(k)之间的相关性。对21例患者的44次血液透析疗程中的氨基糖苷类药物药代动力学进行了研究。从血液透析开始至结束后30分钟测得的庆大霉素和妥布霉素的k(平均0.18 h-1;t1/2 = 3小时51分钟)与测得的肌酐的k(平均0.13 h-1;t1/2 = 5小时20分钟)显著相关,并且如计算机程序所预测的那样,与血液透析期间庆大霉素和妥布霉素的k(平均0.20 h-1,t1/2 = 3小时28分钟)也显著相关。因此,血液透析后30分钟的氨基糖苷类药物血清浓度可用简单的回归方程估算。然而,由于个体患者的实测值和预测值可能存在很大差异,血液透析后监测血清中氨基糖苷类药物的浓度仍然很有必要。